Endocyte Competitors and Similar CompaniesClear all

Endocyte's competitors and similar companies include Cleave Biosciences, Ikena Oncology and TScan Therapeutics.

	Endocyte Endocyte is a biopharmaceutical company that develops receptor-targeted therapeutics to treat cancer and inflammatory diseases.	Cleave Biosciences Cleave Biosciences is a biopharmaceutical company that discovers and develops therapies for the treatment of cancer.	Ikena Oncology Ikena Oncology (formerly Kyn Therapeutics) is a biotechnology company that discovers and develops biomarker-driven therapies for cancer treatment.	TScan Therapeutics TScan Therapeutics is a biotechnology company that develops cancer-targeting therapies.
Founding Date	Founding Date 1995	Founding Date 2010	Founding Date 2016	Founding Date 2018
Type	Type Subsidiary	Type Private	Type Public	Type Public
Tags	Tags Manufacturing & Industrial biotech oncology pharma therapy	Tags Manufacturing & Industrial biotech drug development oncology pharma therapy	Tags Healthcare biotech oncology pharma therapy	Tags Technology biotech oncology pharma therapy
Locations	Locations West Lafayette, US HQ Saint Genis Pouilly, FR Indianapolis, US	Locations Burlingame, US HQ	Locations Boston, US HQ	Locations Waltham, US HQ
Employees	Employees 476% decrease	Employees 3	Employees 5052% increase	Employees 7316% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 82.5 m	Valuation ($) 251.6 m
Financial
Revenue (est.)	Revenue (est.) $70k (FY, 2017)	Revenue (est.) N/A	Revenue (est.) $800k (FY, 2025)	Revenue (est.) $10.3m (FY, 2025)
Net income	Net income ($55.1m) (FY, 2017)	Net income N/A	Net income ($45.3m) (FY, 2025)	Net income ($129.8m) (FY, 2025)
Funding
Total funding raised	Total funding raised $ 41m	Total funding raised $ 129m	Total funding raised $ 49m	Total funding raised $ 137.5m